|
All |
SUDOSCAN risk score |
P-value |
P-value adjusted* |
Risk score ≤ 25 |
Risk score ]25-50] |
Risk score > 50 |
N |
232 |
44 |
149 |
39 |
|
|
Men participants |
140 (60%) |
31 (70%) |
90 (60%) |
19 (49%) |
0.130 |
- |
Diabetes duration (years) |
9 ± 7 |
4 ± 4 |
9 ± 6 |
15 ± 7 |
< 0.001 |
- |
BMI (kg/m2) |
26 ± 4 |
24 ± 3 |
26 ± 3 |
29 ± 4 |
< 0.001 |
- |
Age (years) |
52 ± 9 |
44 ± 8 |
53 ± 8 |
59 ± 7 |
< 0.001 |
- |
HbA1C (%) |
8.5 ± 1. 8 |
7.4 ± 1. 8 |
8.3 ± 1. 5 |
10.3 ± 1.7 |
< 0.001 |
< 0.001 |
SBP (mmHg) |
120 ± 16 |
117 ± 16 |
119 ± 16 |
127 ± 16 |
0.011 |
NS |
DBP (mmHg) |
76 ± 8 |
77 ± 10 |
76 ± 8 |
77 ± 7 |
NS |
NS |
ESC hands (µS) |
59 ± 20 |
72 ± 18 |
58 ± 19 |
46 ± 18 |
< 0.001 |
< 0.001 |
ESC feet (µS) |
59 ± 21 |
77 ± 10 |
58 ± 19 |
43 ± 20 |
< 0.001 |
< 0.001 |
HR variability at rest |
|
|
|
|
|
|
Heart Rate (bpm) |
78 ± 11 |
77 ± 11 |
77 ± 11 |
81 ± 11 |
NS |
NS |
SDNN (ms) |
35 ± 18 |
39 ± 18 |
36 ± 18 |
28 ± 18 |
0.001 |
NS |
RMSSD (ms) |
24 ± 20 |
28 ± 26 |
24 ± 18 |
20 ± 21 |
0.044 |
NS |
TP (ms2) |
1353 ± 1410 |
1688 ± 1447 |
1385 ± 1428 |
851 ± 1168 |
< 0.001 |
0.036 |
VLF (ms2) |
699 ± 752 |
915 ± 849 |
701 ± 751 |
442 ± 549 |
< 0.001 |
0.098 |
LF (ms2) |
355 ± 423 |
392 ± 317 |
384 ± 470 |
200.0 ± 285 |
< 0.001 |
0.079 |
HF (ms2) |
221 ± 371 |
260 ± 442 |
228 ± 359 |
148 ± 322 |
0.002 |
0.047 |
LF/HF |
2.8 ± 2.3 |
3.1 ± 2.3 |
2.7 ± 2.2 |
2.9 ± 2.4 |
NS |
NS |
HR variability during moderate activity |
|
|
|
|
|
|
Heart Rate (bpm) |
93± 11 |
92 ± 12 |
92 ± 11 |
97 ± 10 |
0.017 |
NS |
SDNN (ms) |
70 ± 27 |
76± 27 |
69 ± 27 |
66 ± 24 |
NS |
NS |
RMSSD (ms) |
20 ± 16 |
24 ± 18 |
19 ± 12 |
19 ± 25 |
0.020 |
NS |
TP (ms2) |
1477 ± 1373 |
2059 ± 1591 |
1444 ± 1336 |
942 ± 975 |
< 0.001 |
NS |
VLF (ms2) |
964 ± 932 |
1300 ± 997 |
957 ± 943 |
611 ± 657 |
< 0.001 |
NS |
LF (ms2) |
295 ± 299 |
449 ± 325 |
289 ± 299 |
142 ± 162 |
< 0.001 |
0.019 |
HF (ms2) |
107 ± 228 |
172 ± 415 |
104 ± 166 |
45 ± 74 |
< 0.001 |
0.034 |
LF/HF |
4.8 ± 3.1 |
5.2 ± 3.1 |
4.6 ± 3.1 |
4.9 ± 3.2 |
NS |
NS |
CARTs |
|
|
|
|
|
|
Abnormal E:I ratio (< 1.21) |
46 (20%) |
6 (14%) |
26 (17%) |
14 (36%) |
0.027 |
0.028 |
Abnormal 30:15 ratio (< 1.03) |
71 (31%) |
5 (11%) |
44 (30%) |
22 (56%) |
< 0.001 |
< 0.001 |
Orthostatic hypotension (> 20 mmHg) |
17 (7%) |
3 (7%) |
10 (7%) |
4 (10%) |
NS |
NS |
Data are means ± SD |
|
|
|
|
|
|
*P-value adjusted on gender, diabetes duration and BMI |
